http://www.cancer.gov/cancer_information/doc.aspx?viewid=25FB1A5E-DDFD-4B67-8ECE-B6C62B9A17CD
National Cancer Institute, National Institutes of Health
The summary includes a brief history of hydrazine sulfate research, results of clinical trials, and possible side effects of hydrazine sulfate use. Hydrazine sulfate is a monoamine oxidase (MAO) inhibitor that has been investigated for more than 30 years as a treatment for cancer and as a therapy to decrease cancer-related anorexia (inability to eat) and cachexia (muscle wasting).